Palogic Value Management holds 5,374,949 Health Catalyst shares, equal to 7.1% of the common stock, in an activist position. The stake matters to investors because the position is tied to a September 2026 letter to Health Catalyst, while recent open-market purchases show activity across the fund and managed accounts.
Key Highlights
- Palogic Value Management holds 5,374,949 Health Catalyst common shares, representing 7.1% of the class.
- The activist position is tied to a September 2026 letter addressed to Health Catalyst.
- Palogic Value Fund purchased 174,617 shares on 8/6/2026 at $1.76 per share.
Health Catalyst, Inc. (NASDAQ: HCAT) has an activist Shareholder holding 7.1% of its common stock, with Palogic Value Management reporting 5,374,949 shares. The position is associated with a September 2026 letter to Health Catalyst. The reported stake is based on 75,256,381 common shares outstanding as of Jul 31, 2026.
Palogic’s Health Catalyst Position
Palogic Value Management’s reported holdings include 5,366,087 shares held by Palogic Value Fund, LP. Separately managed accounts account for 8,862 shares included in the ownership figures. The common stock carries a Par Value of $0.001 per share.
Recent Open-Market Purchases
Palogic Value Fund bought 174,617 shares on 8/6/2026 at $1.76 per share. It purchased another 150,834 shares on 8/11/2026 at $1.70 per share, followed by 11,332 shares on 8/17/2026 at $1.70 per share. The fund also bought 1,003 shares on 8/18/2026 at $1.70 per share and 1,000 shares on 8/19/2026 at $1.69 per share. Purchases continued with 86,971 shares on 8/20/2026 at $1.66 per share and 19,260 shares on 8/21/2026 at $1.60 per share. The transactions were open-market purchases, with prices stated per share and excluding commissions. Ryan L. Vardeman signed on behalf of Palogic Value Management, Palogic Capital Management, LLC, Palogic Value Fund, LP and himself on 09/08/2026. Palogic’s reported position therefore represents 7.1% of that share base.



Please wait processing your request...